In this video, Michael J. Bloch, MD, speaks about updates from the Transcatheter Cardiovascular Therapeutics (TCT) 2022 conference, including the results from the RADIANCE II Pivotal Study: A Study of the...
In this commentary, Michael Bloch, MD, writes about using time in therapeutic range (TTR) to determine dose, dietary recommendations, and a possible need to change anticoagulants for patients on warfarin.
...
How do patterns of blood pressure change over the life course and differ between men and women? A new analysis contradicts what you think you know. Lead researcher Susan Cheng, MD, MPH, MMSc, offers her...
Luke Joseph Laffin, MD, from the Cleveland Clinic Foundation, answers our questions about his research on the effect of phase 2 cardiac rehabilitation on exercise capacity and outcomes in patients with...
In this article, Michael J. Bloch, MD, writes about studies over the past 30 years that prove lower achieved blood pressure, including modest reductions in blood pressure, translates to lower cardiovascular...
In this article, Michael J. Bloch, MD, writes about studies over the past 30 years that prove lower achieved blood pressure, including modest reductions in blood pressure, translates to lower cardiovascular...
In this commentary, Michael Bloch, MD, writes about the cardiovascular risk of exposure to ambient air pollution and how clinicians can play a role in mitigating exposure to reduce blood pressure and...
Christianne Roumie, MD, MPH, answers our questions about her new study, which compared the incidence of diabetes and impaired fasting glucose among participants from the SPRINT Randomized Trial.
In this Editorial, Editorial Board Member Michael J. Bloch, MD, reflects on a 1985 article from Consultant’s archives about how to properly use the laboratory to monitor drug therapy among patients with...
In this podcast, Alexander Rothman, PhD, discusses his team's latest analysis of CANTOS, which evaluated whether interleukin-1β inhibition would reduce blood pressure, prevent incident...
